Comorbid diseases in patients with lichen planus in Jordan: A comparative case control Study
Main Article Content
Keywords
Lichen planus comorbidities, Diabetes, Dyslipidemia, Jordan, thyroid disease
Abstract
Lichen Planus (LP) is an immune mediated inflammatory skin condition characterized by the presence of pruritic purplish papular rash. We aimed to assess comorbid conditions such as diabetes mellitus, dyslipidemias, metabolic syndrome, vitamin D deficiency, hypothyroidism, hepatitis C virus, and autoimmune disease in lichen planus patients in Jordan. A case-control study was conducted among 102 cases with age and gender-matched 102 controls. A thorough clinical exam and blood testing of fasting blood glucose, lipid profile, Vitamin D and B12, thyroid function, uric acid, and hepatitis C status were done. The mean age of patients was 43.7± 16 years, and females predominated 58 (57%). The cases had higher levels of blood glucose (p-value 0.03), LDL (0.001), TG (p-value 0.001), total
cholesterol (p-value 0.001), uric acid (p-value 0.001) and systolic blood pressure (p-value 0.001), and lower levels of HDL (p-value 0.001), vitamin D (p-value 0.001), and T4 (p-value 0.001) compared to controls. However, there was no significant difference regarding TSH, B12, and hepatitis C status. After adjustment of age and gender, linear regression revealed that all findings were similar. The study
revealed that LP patients had significant alternations with comorbid conditions such as high blood glucose, dyslipidemias, low thyroid hormone, low vitamin D levels, low uric acid levels, and high blood pressure.
References
2. Shiohara T, Moriya N, Nagashima M. Induction and control of lichenoid tissue reactions. Springer Semin Immunopathol. 1992;13(3-4):369-385. doi:10.1007/BF00200535
3. Shiohara T, Moriya N, Tsuchiya K, Nagashima M, Narimatsu H. Lichenoid tissue reaction induced by local transfer of Ia-reactive T-cell
clones. J Invest Dermatol. 1986;87(1):33-38. doi:10.1111/1523-1747.ep12523539
4. Boch K, Langan EA, Kridin K, Zillikens D, Ludwig RJ, Bieber K. Lichen Planus. Front Med (Lausanne). 2021;8:737813. Published 2021 Nov
1. doi:10.3389/fmed.2021.737813
5. Sugerman PB, Satterwhite K, Bigby M. Autocytotoxic T-cell clones in lichen planus. Br J Dermatol. 2000;142(3):449-456. doi:10.1046/j.1365-2133.2000.03355.x
6. Scully C, el-Kom M. Lichen planus: review and update on pathogenesis. J Oral Pathol. 1985;14(6):431-458. doi:10.1111/j.1600-
0714.1985.tb00516.x
7. Lacy MF, Reade PC, Hay KD. Lichen planus: a theory of pathogenesis. Oral Surg Oral Med Oral Pathol. 1983;56(5):521-526. doi:10.1016/0030-4220(83)90100-7
8. Sugerman PB, Savage NW, Walsh LJ, et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med. 2002;13(4):350-365.
doi:10.1177/154411130201300405
9. Zhang J, Zhou G, Du GF, Xu XY, Zhou HM. Biologics, an alternative therapeutic approach for oral lichen planus. J Oral Pathol Med.
2011;40(7):521-524. doi:10.1111/j.1600- 0714.2011.01029.x
10. Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A. Pathogenesis of oral lichen planus--a review. J Oral Pathol Med. 2010;39(10):729-734. doi:10.1111/j.1600-0714.2010.00946.x
11. Lodi G, Giuliani M, Majorana A, et al. Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review. Br J Dermatol. 2004;151(6):1172-1181. doi:10.1111/j.1365-2133.2004.06257.x
12. Alaizari NA, Al-Maweri SA, Al-Shamiri HM, Tarakji B, Shugaa-Addin B. Hepatitis C virus infections in oral lichen planus: a systematic
review and meta-analysis. Aust Dent J. 2016;61(3):282-287. doi:10.1111/adj.12382
13. Nosratzahi T, Raiesi M, Shahryari B. Lack of Association between Oral Lichen Planus and Hepatitis B and C Virus Infection - a Report from Southeast Iran. Asian Pac J Cancer Prev. 2018;19(6):1633-1637. Published 2018 Jun 25. doi:10.22034/APJCP.2018.19.6.1633
14. Piraccini BM, Saccani E, Starace M, Balestri R, Tosti A. Nail lichen planus: response to treatment and long term follow-up. Eur J Dermatol. 2010;20(4):489-496. doi:10.1684/ejd.2010.0952
15. Mignogna MD, Lo Muzio L, Lo Russo L, Fedele S, Ruoppo E, Bucci E. Oral lichen planus:different clinical features in HCV-positive and
HCV-negative patients. Int J Dermatol. 2000;39(2):134-139. doi:10.1046/j.1365- 4362.2000.00903.x
16. Halevy S, Shai A. Lichenoid drug eruptions. J Am Acad Dermatol. 1993;29(2 Pt 1):249-255. doi:10.1016/0190-9622(93)70176-t
17. Arnold DL, Krishnamurthy K. Lichen Planus. 2022 Oct 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 30252382.
18. Le Cleach L, Chosidow O. Clinical practice. Lichen planus. N Engl J Med. 2012;366(8):723- 732. doi:10.1056/NEJMcp1103641
19. Kofoed ML, Wantzin GL. Familial lichen planus. More frequent than previously suggested?. J Am Acad Dermatol. 1985;13(1):50-54.
doi:10.1016/s0190-9622(85)70142-9
20. Ergun S, Troşala SC, Warnakulasuriya S, et al. Evaluation of oxidative stress and antioxidant profile in patients with oral lichen planus. J Oral Pathol Med. 2011;40(4):286-293. doi:10.1111/j.1600-0714.2010.00955.x
21. Ying J, Xiang W, Qiu Y, Zeng X. Risk of metabolic syndrome in patients with lichen planus: A systematic review and metaanalysis. PLoS One. 2020;15(8):e0238005. Published 2020 Aug 21. doi:10.1371/journal.pone.0238005
22. Ilves L, Ottas A, Raam L, et al. Changes in Lipoprotein Particles in the Blood Serum of Patients with Lichen Planus. Metabolites.
2023;13(1):91. Published 2023 Jan 6. doi:10.3390/metabo13010091
23. Kumar SA, Krishnam Raju PV, Gopal KVT, Rao TN. Comorbidities in Lichen Planus: A Casecontrol Study in Indian Patients. Indian Dermatol Online J. 2019;10(1):34-37. doi:10.4103/idoj.IDOJ_48_18
24. Aryanian Z, Shirzadian A, Hatami P, Dadras H. High Incidence of Metabolic Syndrome Components in Lichen Planus Patients: A
Prospective Cross-Sectional Study. Int J Clin Pract. 2022;2022:7184678. Published 2022 Jan
31. doi:10.1155/2022/7184678
25. Bahramian A, Bahramian M, Mehdipour M, et al. Comparing Vitamin D Serum Levels in Patients with Oral Lichen Planus and Healthy Subjects. J Dent (Shiraz). 2018;19(3):212-216.
26. Akanksha Gupta, Ravi Prakash Sasankoti Mohan, Nagaraju Kamarthi, Sangeeta Malik, Sumit Goel et al. (2017) Serum Vitamin D Level in Oral Lichen Planus Patients of North India- A CaseControl Study.. Journal of Dermatologic Research And Therapy - 1(2):19-35.https://doi.org/10.14302/issn.2471-2175.jdrt-17- 1481
27. Chakraborti G, Biswas R, Chakraborti S, Sen PK. Altered serum uric Acid level in lichen planus patients. Indian J Dermatol. 2014;59(6):558-561. doi:10.4103/0019-5154.143510.
28. Yasuda D, Takahashi K, Kakinoki T, Tanaka Y, Ohe T, Nakamura Sh , Mashino T, 2013, 4, 527, undefined. Synthesis, radical scavenging activity and structure–activity relationship of uric acid analogs. pubs.rsc.org; Available from:https://pubs.rsc.org/en/content/articlehtml/2012/md/c2md20287e. DOI: 10.1039/c2md20287e
29. Christensen E, Holmstrup P, Wiberg-Jorgensen F, Neumann-Jensen B, Pindborg JJ. Arterial blood pressure in patients with oral lichen
planus. J Oral Pathol. 1977;6(3):139-142. doi:10.1111/j.1600-0714.1977.tb01874.x
30. LYNCH FW. An apparent association of lichen planus with vascular hypertension. J Invest Dermatol. 1949;13(1):43-45.
doi:10.1038/jid.1949.64
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.